Axogen, Inc.
AXGN· Nasdaq
Released Nov 7, 2024, before the open
10-Q filed Nov 7, 2024, 38 days after period end · 0000805928-24-000137
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $48.64M | $41.27M | $36.96M | $31.20M |
| Net Income | -$1.86M | -$4.09M | -$4.32M | -$7.14M |
| EPS Diluted |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.10 |
| -$0.10 |
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.